Stokes Healthcare has rebranded its New Jersey outsourcing facility. Formerly Stokes 503B, the newly launched Epicur Pharma is a 503B-registered facility under the U.S. Food and Drug Administration (FDA). The agency’s 503B standards are reflective of its Current Good Manufacturing Practice (CGMP) regulations, which assure “the identity, strength, quality, and purity” of drug products by requiring the control of their manufacturing operations, FDA says. “This level of reliability reduces practice liability, improves patient outcomes, and allows veterinarians to fully trust in the medications they use and prescribe,” Stokes Healthcare says.
